On Monday, Aug. 23, the FDA authorized full approval for one COVID-19 vaccine. The vaccine known as the Pfizer-BioNTech COVID-19 Vaccine, will now be marketed as Comirnaty for the prevention of …
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you had a login with the previous version of our e-edition, then you already have a login here. You just need to reset your password by clicking here.
If you are a current print subscriber, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
|
On Monday, Aug. 23, the FDA authorized full approval for one COVID-19 vaccine. The vaccine known as the Pfizer-BioNTech COVID-19 Vaccine, will now be marketed as Comirnaty for the prevention of COVID-19 disease in individuals 16 years of age and older.
“The FDA’s full approval of the Pfizer COVID-19 vaccine offers Iowans and Americans who’ve not yet been vaccinated the assurance they need to do so now,” stated Governor Reynolds. “The vaccine is the best defense against the virus, and it’s been proven highly effective at preventing serious illness, hospitalization and death, even against variants. Vaccine is widely available in the state, and I encourage all eligible Iowans to get vaccinated as soon as possible.”
The Comirnaty vaccine continues to be available under emergency use authorization (EUA), for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
Vaccine supply in the state is stable and vaccine appointments are readily available statewide. The IDPH encourages anyone with questions to reach out to their health care provider.